# Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.

> **NCT05321251** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Neurotrophic Keratitis

## Interventions

- **DRUG:** Insulin
- **PROCEDURE:** Tarsorrhaphy

## Key facts

- **NCT ID:** NCT05321251
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never commenced due to logistical issues.
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05321251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05321251, "Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT05321251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*